Skip to main content
SpringerLink
Log in

Researchers from France conclude that “proton pump inhibitors [PPIs] should not be administered during methotrexate treatment”

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Santucci R, Leveque D, Lescoute A, Kemmel V, Herbrecht R.Delayed elimination of methotrexate associated with co-administration of proton pump inhibitors. Anticancer Research 30: 3807-10, No. 9, 1 Sep 2010

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Researchers from France conclude that “proton pump inhibitors [PPIs] should not be administered during methotrexate treatment”. React. Wkly. 1328, 3 (2010). https://doi.org/10.2165/00128415-201013280-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013280-00006

Keywords

Search

Navigation